Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Mucosal Immunity
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1415475
This article is part of the Research Topic Immune Responses at Barrier Tissues: Insights from Synthetic Biology in Therapeutics, Diagnostics, Mechanisms, and Beyond View all 5 articles

Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis

Provisionally accepted
Emily Webb Emily Webb 1Stefan Petkov Stefan Petkov 2Yun Heejin Yun Heejin 3Laura Else Laura Else 4Limakatso Lebina Limakatso Lebina 5Jennifer Serwanga Jennifer Serwanga 6Azure-Dee A. Pillay Azure-Dee A. Pillay 5Thabiso B. Seiphetlo Thabiso B. Seiphetlo 5Susan Mugaba Susan Mugaba 6Patricia Namubiru Patricia Namubiru 6Geoffrey Odoch Geoffrey Odoch 6Daniel Opoka Daniel Opoka 6Andrew Ssemata Andrew Ssemata 6Pontiano Kaleebu Pontiano Kaleebu 6Saye Khoo Saye Khoo 4N Martinson N Martinson 5Julie Fox Julie Fox 7Clive M. Gray Clive M. Gray 8Carolina Herrera Carolina Herrera 3Francesca Chiodi Francesca Chiodi 2*
  • 1 London School of Hygiene and Tropical Medicine, University of London, London, London, United Kingdom
  • 2 Microbiology, Tumor and Cell Biology, Karolinska Institutet (KI), Solna, Sweden
  • 3 Imperial College London, London, England, United Kingdom
  • 4 University of Liverpool, Liverpool, North West England, United Kingdom
  • 5 University of the Witwatersrand, Johannesburg, South Africa
  • 6 Medical Research Council (Uganda), Entebbe, Uganda
  • 7 King's College London, London, England, United Kingdom
  • 8 University of Cape Town, Cape Town, South Africa

The final, formatted version of the article will be published soon.

    Tight junctions (TJs) serve as permeability filters between the internal and external cellular environment.A large number of proteins have been identified to be localized at the TJs. Due to limitations in tissue collection, TJs in the male genital tract have been understudied.We analysed the transcriptomics of 132 TJ genes in foreskin tissue of men requesting voluntary medical male circumcision (VMMC) and enrolled in the Combined HIV Adolescent Prevention Study (CHAPS) trial conducted in South Africa and Uganda (NCT03986970). The trial evaluated dose requirements for event-driven HIV pre-exposure prophylaxis (PrEP) with emtricitabine-tenofovir (FTC-TDF) or emtricitabine-tenofovir alafenamide (FTC-TAF) during insertive sex. A total of 144 participants were randomized to either control arm or one of 8 PrEP arms (n=16/arm), receiving oral FTC-TDF or FTC-TAF over one or two days. Following in vivo oral PrEP dosing and VMMC, the expression level of three important TJ proteins (CLDN-1, OCN and ZO-1) was measured ex vivo in foreskin tissue by Western blot. Expression of cytokine genes implicated in TJ regulation was determined. Non-parametric Kruskal-Wallis tests were used to compare TJ gene expression and protein levels by type of PrEP received, and Spearman's correlation coefficients were calculated to assess whether TJ gene expression levels were related to cytokine gene levels or to PrEP drug concentrations and their active intracellularly phosphorylated metabolites.A high level of expression in foreskin tissue was found for 118 (of 132) TJ genes analysed; this finding contributed to create a map of TJ components within the male genital tract. Importantly, PrEP regimens tested in the CHAPS trial did not affect the expression of TJ genes and the analysed proteins in the foreskin; thus, further supporting the safety of this prevention strategy against HIV-1 transmission during insertive sex. Additionally, we identified the level of several cytokines' genes to be correlated to TJ gene expression: among them, IL-18, IL-33 and VEGF.TJs can limit viral entry into target cells; to affect this biological function viruses can reduce the expression of TJ proteins. Our study, on the expression and regulation of TJs in the foreskin, contribute important knowledge for PrEP safety and further design of HIV-1 prophylaxis.

    Keywords: emtricitabine tenofovir, pre-exposure prophylaxis PrEP, Foreskin, transcriptomes, Tight Junctions, Cytokines

    Received: 10 Apr 2024; Accepted: 16 Oct 2024.

    Copyright: © 2024 Webb, Petkov, Heejin, Else, Lebina, Serwanga, Pillay, Seiphetlo, Mugaba, Namubiru, Odoch, Opoka, Ssemata, Kaleebu, Khoo, Martinson, Fox, Gray, Herrera and Chiodi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Francesca Chiodi, Microbiology, Tumor and Cell Biology, Karolinska Institutet (KI), Solna, 17177, Sweden

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.